Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Link
https://link.springer.com/content/pdf/10.1007/s00198-022-06495-8.pdf
Reference24 articles.
1. Ramchand SK, David NL, Lee H et al (2021) Effects of combination denosumab and high-dose teriparatide administration on bone microarchitecture and estimated strength: the DATA-HD HR-pQCT study. J Bone Miner Res 36:41–51. https://doi.org/10.1002/jbmr.4161
2. Black DM, Rosen CJ (2016) Clinical practice. Postmenopausal osteoporosis N Engl J Med 374:254–262. https://doi.org/10.1056/NEJMcp1513724
3. Kani JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis In Report of a WHO Study Group. World Health Organ Tech Rep Ser 843:1–129
4. Compston JE, McClung MR, Leslie WD (2019) Osteoporosis Lancet 393:364–376. https://doi.org/10.1016/S0140-6736(18)32112-3
5. Cummings SR, San Martin J, McClung MR et al (2009) Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med 361:756–765. https://doi.org/10.1056/NEJMoa0809493
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Follow-up bone mineral density testing: 2023 official positions of the International Society for Clinical Densitometry;Journal of Clinical Densitometry;2024-01
2. The Effect of Denosumab in Elderly Patients Regarding Bone Density and Fracture Risk;Journal of Bone Metabolism;2023-08-31
3. New insights into the role of long non-coding RNAs in osteoporosis;European Journal of Pharmacology;2023-07
4. Comparison of the Efficacy of Zoledronate Acid or Denosumab After Switching from Romosozumab in Japanese Postmenopausal Patients;Calcified Tissue International;2023-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3